Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5 knockdown suppresses gastric cancer progression by reducing the expression of long non-coding RNA TUG1. | Toxicol Res (Camb) | 2025 | 39830887 | PubTator, text mining | PubMed |
| Overexpression of FTO alleviates traumatic brain injury induced posttraumatic epilepsy by upregulating NR4A2 expression via m6A demethylation. | Funct Integr Genomics | 2025 | 39825968 | PubTator, text mining | PubMed |
| Enhancing staging in multiple myeloma using an m6A regulatory gene-pairing model. | Clin Exp Med | 2025 | 39820586 | PubTator, text mining | PubMed |
| ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner. | Mol Cancer | 2025 | 39815301 | PubTator, text mining | PubMed |
| FTO Alleviates Hepatic Ischemia-Reperfusion Injury by Regulating Apoptosis and Autophagy. | Gastroenterol Res Pract | 2025 | 39811145 | PubTator, text mining | PubMed |
| hnRNPA2B1 drives colorectal cancer progression via the circCDYL/EIF4A3/PHF8 axis. | Kaohsiung J Med Sci | 2025 | 39810713 | PubTator, text mining | PubMed |
| RNA m6A involves in regulation of oxidative stress and apoptosis may via NF-kB pathway in cadmium-induced lung cells. | Cell Death Discov | 2025 | 39794323 | PubTator, text mining | PubMed |
| ALKBH5, an m6A demethylase, attenuates tumor growth and inhibits metastasis in papillary thyroid carcinoma. | Sci Rep | 2025 | 39789120 | PubTator, text mining | PubMed |
| Targeting m6A demethylase FTO to heal diabetic wounds with ROS-scavenging nanocolloidal hydrogels. | Biomaterials | 2025 | 39756272 | PubTator, text mining | PubMed |
| Diagnostic value and immune infiltration characterization of WTAP as a critical m6A regulator in liver transplantation. | Hepatobiliary Pancreat Dis Int | 2025 | 39730289 | PubTator, text mining | PubMed |
| N6-methyladenosine mediated-NRF2 signaling pathway attenuates cadmium cytotoxicity by inhibiting oxidative damage in bronchial epithelial cells. | Toxicol Lett | 2025 | 39725363 | PubTator, text mining | PubMed |
| Cis-Regulation of an m6A Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma. | Adv Sci (Weinh) | 2025 | 39680684 | PubTator, text mining | PubMed |
| YTHDF2 promotes arsenic-induced malignant phenotypes by degrading PIDD1 mRNA in human keratinocytes. | Chem Biol Interact | 2025 | 39675544 | PubTator, text mining | PubMed |
| The N6-methyladenosine demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification. | Cardiovasc Res | 2025 | 39658001 | PubTator, text mining | PubMed |
| MDV-encoded protein kinase US3 phosphorylates WTAP to inhibit transcriptomic m6A modification and cellular protein translation. | Vet Microbiol | 2025 | 39644648 | PubTator, text mining | PubMed |
| Energy Stress-Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma. | Cancer Res | 2025 | 39636740 | PubTator, text mining | PubMed |
| tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10. | Cell Signal | 2025 | 39617358 | PubTator, text mining | PubMed |
| Role of the m6A demethylase ALKBH5 in gastrointestinal tract cancer (Review). | Int J Mol Med | 2025 | 39611478 | PubTator, text mining | PubMed |
| YTHDF2 contributes to psoriasis by promoting proliferation and inflammatory response through regulation of the Wnt signaling pathway. | Int Immunopharmacol | 2025 | 39608173 | PubTator, text mining | PubMed |
| Visualization and Quantification of Single-Base m6A Methylation. | Angew Chem Int Ed Engl | 2025 | 39584935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=7